Addressing Unmet Needs in the Treatment of Schizophrenia: The Role of the Pharmacist
This activity will review the updated clinical practice guidelines in schizophrenia, offering guidance on patient assessment, pharmacologic treatment, and psychosocial support.
Advances in Migraine Treatment: What the Pharmacist Needs to Know
Explore pathophysiology, incidence, and treatment challenges associated with migraine
The Evolving Treatment Landscape for Neuromyelitis Optica Spectrum Disorder: Updates for Specialty and Infusion Pharmacists
Examine the patient population afflicted with neuromyelitis optica spectrum disorder (NMOSD), including factors related to epidemiology, etiology, pathophysiology, clinical presentation, and diagnostic challenges
Managing Multiple Sclerosis: Examining Oral Treatment Options and Specialty Pharmacy Considerations
Analyze the latest data on the efficacy, safety, and administration of oral disease-modifying therapies (DMTs) for the treatment of MS